Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varilrix HSA-free versus Varilrix two-dose varicella vaccine study in toddlers
2013-003535-30Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2015
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varicella virus vaccine live in chickenpox (2 arms), sponsored by GSK. Primary endpoint: Assessment of fever after varicella vaccination post Dose 1. Started Jul 2015; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on 2013-003535-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003535-30.